Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With de Novo Coronary Artery Lesions”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Post-approval studies (Phase 4)Study completedNCT00495898
What this trial is testing

Diabetic Patients With De Novo Native Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 200
Large-scale testing (Phase 3)Study completedNCT00232791
What this trial is testing

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 102
Large-scale testing (Phase 3)UnknownNCT02360423
What this trial is testing

Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
CID S.p.A. 430
Large-scale testing (Phase 3)Study completedNCT00232752
What this trial is testing

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 100
Not applicableStudy completedNCT01168830
What this trial is testing

First in Man Trial - BIOSOLVE-I

Who this might be right for
de Novo Lesions in Native Coronary Arteries
Biotronik AG 46
Not applicableUnknownNCT02360709
What this trial is testing

Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
CID S.p.A. 800
Testing effectiveness (Phase 2)Study completedNCT00934752
What this trial is testing

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Who this might be right for
Coronary Artery Stenosis
C. R. Bard 24
Large-scale testing (Phase 3)Study completedNCT00235170
What this trial is testing

The Arterial Revascularization Therapies Study Part II.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 607
Post-approval studies (Phase 4)Ended earlyNCT00917163
What this trial is testing

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 13
Post-approval studies (Phase 4)Study completedNCT00402272
What this trial is testing

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 2,700
Not applicableStudy completedNCT02086006
What this trial is testing

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 16
Not applicableStudy completedNCT02009956
What this trial is testing

EXCELLA Post-Approval Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 57
Post-approval studies (Phase 4)Study completedNCT01171820
What this trial is testing

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 324
Large-scale testing (Phase 3)Study completedNCT00130546
What this trial is testing

Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)

Who this might be right for
Coronary Artery Disease
University Hospital Freiburg 112
Large-scale testing (Phase 3)Study completedNCT00165035
What this trial is testing

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Who this might be right for
Coronary Disease
Cordis US Corp. 1,701
Not applicableStudy completedNCT02542007
What this trial is testing

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

Who this might be right for
Coronary Arteriosclerosis
OrbusNeich 440
Post-approval studies (Phase 4)Study completedNCT00235066
What this trial is testing

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 100
Not applicableUnknownNCT02698839
What this trial is testing

Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Who this might be right for
Coronary Artery Disease
Sino Medical Sciences Technology Inc. 539
Not applicableStudy completedNCT01759290
What this trial is testing

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Who this might be right for
Chronic Total Occlusion of Coronary ArteryCoronary OcclusionCoronary Artery Disease+4 more
Abbott Medical Devices 1,800
Testing effectiveness (Phase 2)Study completedNCT00233779
What this trial is testing

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 52
Next Page